How Much Weight Can You Lose on 1mg Wegovy?

Free clinical consultation — a named GPhC-registered prescriber personally reviews your answers the same day
Free prescription issued where clinically suitable, with no separate dispensing fee
Free next-working-day tracked delivery by DPD, dispatched the same day if you order before 12pm once approved
Priority aftercare seven days a week, included — no add-ons, no subscription

At 1mg, Wegovy is a titration step on the way to its maintenance dose, not a long-term landing point. Most people reach 1mg semaglutide after roughly eight weeks and continue titrating upward, so the weight loss at this stage reflects early progress rather than the full picture the overall Wegovy programme can deliver. These are prescription-only medicines; a GPhC-registered prescriber decides whether treatment is clinically appropriate for you, and your dose schedule is set by them, not by any chart online.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the 1mg step actually means for your progress, and how to think about cost alongside it

Why your weight loss at 1mg is real, but incomplete

The dose schedule for Wegovy runs from 0.25mg to a standard maintenance dose of 2.4mg, with steps at 0.5mg, 1mg and 1.7mg along the way. Each step lasts around four weeks, so 1mg is typically where you are in weeks nine to twelve of treatment. By that point, appetite suppression is building and most people have already lost some weight, but the clinical trial evidence that makes headlines refers to what happens over 68 weeks at the 2.4mg maintenance dose.

In STEP 1, published in the New England Journal of Medicine, adults on semaglutide 2.4mg lost an average of around 15% of body weight over 68 weeks alongside lifestyle changes. At the 1mg mark you are still months away from that outcome. Some people feel the dose working clearly at this stage; others notice modest changes and find things accelerate once their prescriber moves them up. Both are normal, and neither is a signal to stop.

The 2.4mg maintenance dose is where the trial results were recorded, and the 1.7mg step sits just before it. Understanding where 1mg sits on that path matters before you make any decisions about whether treatment is delivering what you hoped.

What private Wegovy costs in the UK, and what often gets left out of the headline figure

Private treatment with Wegovy is priced per four-week pen, and that price shifts as doses increase. Since Eli Lilly raised its Mounjaro list price in September 2025, the UK private market for GLP-1 weight-loss medicines has been re-pricing broadly; for context, private semaglutide costs typically range somewhere in the region of £149 to £375 per month depending on the dose and the provider, though those figures move and vary, treat them as indicative rather than fixed. The current Wegovy pricing picture is worth reading if cost is the central question for you.

What matters is what that number actually includes. Headline prices sometimes cover the pen alone. Separately, you may find consultation fees, prescription charges, delivery costs and follow-up reviews sitting outside the figure quoted upfront. That adds up, particularly on a medicine that requires clinical review before each new pen is issued. A question worth asking any provider: is every repeat order re-reviewed by a prescriber, or is it automated once you're set up?

If you are based in Scotland, private Wegovy pricing in Scotland broadly follows the same market, though NHS access routes differ between nations.

What the one price at nume actually covers

We are not the cheapest option. That is a choice, not an oversight. The single price at nume covers the clinical consultation, the prescription, the medicine itself, and free next-working-day delivery, your pen arrives in a plain, unbranded DPD box with a tracking link sent to your phone, and the KwikPen inside is refrigerated during transit. There are no subscription commitments. Every repeat is re-reviewed by a GPhC-registered Independent Prescriber before it is issued; a real clinician reads your update, not software.

Our pharmacy holds GPhC premises registration 9012878, which you can verify on the GPhC register directly. Medicines come through the licensed UK supply chain, with Novo Nordisk as the manufacturer. Aftercare is available seven days a week. There are no discount codes, no promotional pricing and no vouchers, not because we forgot, but because running them on a prescription medicine would be the wrong thing to do. What we focus on instead is the service around it.

You can read more about the team behind nume, including our approach to clinical oversight, or explore the treatment options we support more broadly.

Why cost-per-pen is the wrong question for a prescription medicine

For a prescription-only medicine, the cheapest listing answers the wrong question. The MHRA has warned publicly about fake weight-loss pens circulating through social media and unverified sellers, in 2025, around 20 million doses of illegally traded weight-loss medicines worth approximately £45m were seized, and the first UK site manufacturing counterfeit tirzepatide pens was raided. Semaglutide pens are among the most counterfeited medicines in the UK right now. A seller offering them at a noticeably low price with no visible clinical process attached is a red flag worth taking seriously.

The right question is whether the provider is GPhC-registered, whether the medicines come from the licensed supply chain, and whether a qualified prescriber is making decisions about your care. If you want to check any online pharmacy yourself, the GPhC register is the place to do it. Suspect sellers can be reported via the MHRA's Yellow Card scheme.

If you are considering Wegovy and want to understand the full results picture before deciding, the week-by-week weight loss on Wegovy page covers what the data shows at different points in treatment. When you are ready to take the next step, check your eligibility through a free consultation with our prescribers.

Check your eligibility

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions